Pages that link to "Q49078528"

The following pages link to Michaelis-Menten constraints improved cerebral glucose metabolism and regional lumped constant measurements with [18F]fluorodeoxyglucose (Q49078528):

Displaying 29 items.

• FDG kinetic modeling in small rodent brain PET: optimization of data acquisition and analysis (Q30659338) (← links)
• FDG-PET imaging in mild traumatic brain injury: a critical review (Q30730474) (← links)
• Brain metabolism during short-term starvation in humans (Q34346503) (← links)
• Spectral analysis: principle and clinical applications (Q35566738) (← links)
• Glucagon-like peptide-1 decreases intracerebral glucose content by activating hexokinase and changing glucose clearance during hyperglycemia (Q36459067) (← links)
• Glucagon-like peptide-1 (GLP-1) raises blood-brain glucose transfer capacity and hexokinase activity in human brain (Q36718544) (← links)
• In Alzheimer's Disease, 6-Month Treatment with GLP-1 Analog Prevents Decline of Brain Glucose Metabolism: Randomized, Placebo-Controlled, Double-Blind Clinical Trial (Q36928283) (← links)
• The Effects of Capillary Transit Time Heterogeneity (CTH) on the Cerebral Uptake of Glucose and Glucose Analogs: Application to FDG and Comparison to Oxygen Uptake (Q37336539) (← links)
• Density of perfused capillaries in living human brain during functional activation. (Q41097730) (← links)
• The power of FDG-PET to detect treatment effects is increased by glucose correction using a Michaelis constant (Q42424800) (← links)
• Kinetic characterization of hexokinase isoenzymes from glioma cells: implications for FDG imaging of human brain tumors. (Q43570120) (← links)
• The (18)F-fluorodeoxyglucose lumped constant determined in human brain from extraction fractions of (18)F-fluorodeoxyglucose and glucose (Q43697343) (← links)
• Double-injection FDG method to measure cerebral glucose metabolism twice in a single procedure (Q43729577) (← links)
• Regional analyses of CNS microdialysate glucose and lactate in seizure patients (Q44210441) (← links)
• PET studies of net blood-brain clearance of FDOPA to human brain: age-dependent decline of [18F]fluorodopamine storage capacity (Q45281367) (← links)
• Correction for the effect of rising plasma glucose levels on quantification of MR(glc) with FDG-PET. (Q46084906) (← links)
• Blood-Brain Glucose Transfer in Alzheimer's disease: Effect of GLP-1 Analog Treatment (Q47110521) (← links)
• 6-[18F]fluoro-L-dopa metabolism in living human brain: a comparison of six analytical methods (Q48366038) (← links)
• Cerebral effects of a single dose of intravenous vinpocetine in chronic stroke patients: a PET study (Q48371064) (← links)
• NMR determination of intracerebral glucose concentration and transport kinetics in rat brain (Q48486389) (← links)
• In vivo estimation of cerebral blood flow, oxygen consumption and glucose metabolism in the pig by [15O]water injection, [15O]oxygen inhalation and dual injections of [18F]fluorodeoxyglucose. (Q48518620) (← links)
• Calculation of the FDG lumped constant by simultaneous measurements of global glucose and FDG metabolism in humans (Q48532445) (← links)
• Glucose uptake and lumped constant variability in normal human hearts determined with [18F]fluorodeoxyglucose (Q48778079) (← links)
• Transport of D-glucose and 2-fluorodeoxyglucose across the blood-brain barrier in humans (Q48968980) (← links)
• Correlation between crossed cerebellar diaschisis and clinical neurological scales (Q49021146) (← links)
• A fuzzy model of glucose regulation (Q51162078) (← links)
• Alteration of the regional cerebral glucose metabolism in healthy subjects by glucose loading. (Q51286113) (← links)
• Trajectories of Brain Lactate and Re-visited Oxygen-Glucose Index Calculations Do Not Support Elevated Non-oxidative Metabolism of Glucose Across Childhood (Q58750407) (← links)
• Noninvasive quantification of local cerebral metabolic rate of glucose for clinical application using positron emission tomography and 18F-fluoro-2-deoxy-D-glucose (Q80761857) (← links)